Karla Rubio

778 total citations
21 papers, 338 citations indexed

About

Karla Rubio is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karla Rubio has authored 21 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karla Rubio's work include RNA modifications and cancer (8 papers), RNA Research and Splicing (5 papers) and Epigenetics and DNA Methylation (4 papers). Karla Rubio is often cited by papers focused on RNA modifications and cancer (8 papers), RNA Research and Splicing (5 papers) and Epigenetics and DNA Methylation (4 papers). Karla Rubio collaborates with scholars based in Germany, Mexico and France. Karla Rubio's co-authors include Guillermo Barreto, Stephanie Dobersch, Pouya Sarvari, Indrabahadur Singh, Gergana Dobreva, Thomas Braun, Małgorzata Wygrecka, Stefan Günther, Julio Cordero and Frouzandeh Mahjoubi and has published in prestigious journals such as Nature Communications, Nature Genetics and The FASEB Journal.

In The Last Decade

Karla Rubio

20 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karla Rubio Germany 12 189 74 47 29 28 21 338
Hassen Kamoun Tunisia 15 266 1.4× 55 0.7× 34 0.7× 27 0.9× 26 0.9× 60 482
Weixiang He China 10 192 1.0× 69 0.9× 106 2.3× 17 0.6× 19 0.7× 20 374
Meng Jiang China 9 173 0.9× 123 1.7× 45 1.0× 14 0.5× 19 0.7× 23 336
Vincent J. Concel United States 10 159 0.8× 87 1.2× 81 1.7× 15 0.5× 19 0.7× 14 318
Xiaomin Wu United States 10 194 1.0× 47 0.6× 106 2.3× 43 1.5× 29 1.0× 31 404
Richard Kin Ting Kam Hong Kong 9 251 1.3× 33 0.4× 30 0.6× 25 0.9× 19 0.7× 12 428
Daoyuan Lv China 9 229 1.2× 47 0.6× 16 0.3× 38 1.3× 10 0.4× 11 381
Aleksandra Dąbrowska United Kingdom 7 197 1.0× 102 1.4× 11 0.2× 37 1.3× 19 0.7× 8 316
Jianjun Huang China 11 149 0.8× 58 0.8× 48 1.0× 24 0.8× 7 0.3× 31 313

Countries citing papers authored by Karla Rubio

Since Specialization
Citations

This map shows the geographic impact of Karla Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla Rubio more than expected).

Fields of papers citing papers by Karla Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla Rubio. The network helps show where Karla Rubio may publish in the future.

Co-authorship network of co-authors of Karla Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Karla Rubio. A scholar is included among the top collaborators of Karla Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla Rubio. Karla Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubio, Karla, et al.. (2025). Epigenetic and Transcriptional Reprogramming in 3D Culture Models in Breast Cancer. Cancers. 17(23). 3830–3830.
2.
Sarvari, Pouya, et al.. (2024). ncRNAs Orchestrate Chemosensitivity Induction by Neddylation Blockades. Cancers. 16(4). 825–825. 1 indexed citations
3.
Limón, Ilhuicamina Daniel, J. Martínez‐Juárez, Julián Torres-Jácome, et al.. (2024). Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health. Frontiers in Genetics. 14. 20 indexed citations
4.
Cordero, Julio, Karla Rubio, Witold Szymański, et al.. (2024). Nuclear microRNA 9 mediates G-quadruplex formation and 3D genome organization during TGF-β-induced transcription. Nature Communications. 15(1). 10711–10711. 5 indexed citations
5.
Ouidja, Mohand Ouidir, Denis Biard, Minh Bao Huynh, et al.. (2024). Genetic variability in proteoglycan biosynthetic genes reveals new facets of heparan sulfate diversity.. PubMed. 68(4). 555–578. 1 indexed citations
6.
Rubio, Karla, Estefani Yaquelin Hernández‐Cruz, Pouya Sarvari, et al.. (2023). Nutriepigenomics in Environmental-Associated Oxidative Stress. Antioxidants. 12(3). 771–771. 23 indexed citations
7.
Swain, Jitendriya, Peggy Mérida, Karla Rubio, et al.. (2023). F-actin nanostructures rearrangements and regulation are essential for SARS-CoV-2 particle production in host pulmonary cells. iScience. 26(8). 107384–107384. 2 indexed citations
8.
Rubio, Karla, et al.. (2023). EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs. International Journal of Molecular Sciences. 24(15). 12302–12302. 21 indexed citations
9.
Rubio, Karla, Pouya Sarvari, Julio Cordero, et al.. (2023). Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer. Theranostics. 13(8). 2384–2407. 19 indexed citations
10.
Sarvari, Pouya, et al.. (2022). Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. International Journal of Molecular Sciences. 23(17). 9521–9521. 19 indexed citations
11.
Sarvari, Pouya, et al.. (2022). Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs. Biomolecules. 12(4). 513–513. 9 indexed citations
12.
Ouidja, Mohand Ouidir, Denis Biard, Sandrine Chantepie, et al.. (2022). Variability in proteoglycan biosynthetic genes reveals new facets of heparan sulfates diversity. A systematic review and analysis. medRxiv. 1 indexed citations
13.
Rubio, Karla, Rosa María Ordóñez‐Razo, Guillermo Barreto, et al.. (2022). ADAR1 Isoforms Regulate Let-7d Processing in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences. 23(16). 9028–9028. 6 indexed citations
14.
Rubio, Karla, et al.. (2021). Combining ALT/AST Values with Surgical APGAR Score Improves Prediction of Major Complications after Hepatectomy. PubMed. 4(4). 656–670. 2 indexed citations
15.
Chen, Xiangyu, Yamei Li, Karla Rubio, et al.. (2021). Lymphoid-specific helicase in epigenetics, DNA repair and cancer. British Journal of Cancer. 126(2). 165–173. 19 indexed citations
16.
Rubio, Karla, et al.. (2020). Non-coding RNAs and nuclear architecture during epithelial-mesenchymal transition in lung cancer and idiopathic pulmonary fibrosis. Cellular Signalling. 70. 109593–109593. 24 indexed citations
17.
Castillo, Ximena, Susana Castro‐Obregón, Benjamín Gutiérrez-Becker, et al.. (2019). Re-thinking the Etiological Framework of Neurodegeneration. Frontiers in Neuroscience. 13. 728–728. 60 indexed citations
18.
Mamazhakypov, Argen, Anna Birnhuber, Jochen Wilhelm, et al.. (2019). Loss of LRP1 promotes acquisition of contractile-myofibroblast phenotype and release of active TGF-β1 from ECM stores. Matrix Biology. 88. 69–88. 35 indexed citations
19.
Dobersch, Stephanie, Karla Rubio, & Guillermo Barreto. (2019). Pioneer Factors and Architectural Proteins Mediating Embryonic Expression Signatures in Cancer. Trends in Molecular Medicine. 25(4). 287–302. 18 indexed citations
20.
Singh, Indrabahadur, Julio Cordero, Karla Rubio, et al.. (2018). MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolar organization. Nature Genetics. 50(7). 990–1001. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026